Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
QUESTO SIMBOLO NON E' PIU' ATTIVO

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership96,675 shares
Latest Disclosed Value $ 586,817
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.50% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 96,675 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $586,817 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 96,195 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 0.50% during the quarter. The current value of the position is $1,400,821 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP AMICUS THERAPEUTICS EC US03152W1099 96,675 480 0.50 587 -35.75 0.0078
2025-04-25 2025-02-28 NP AMICUS THERAPEUTICS EC US03152W1099 96,195 1,981 2.10 913 -2.98 0.0123
2025-01-27 2024-11-30 NP AMICUS THERAPEUTICS EC US03152W1099 94,214 672 0.72 940 -13.44 0.0127
2024-10-29 2024-08-31 NP AMICUS THERAPEUTICS EC US03152W1099 93,542 21,535 29.91 1,086 54.04 0.0161
2024-07-26 2024-05-31 NP AMICUS THERAPEUTICS EC US03152W1099 72,007 925 1.30 706 -22.61 0.0112
2024-04-24 2024-02-29 NP AMICUS THERAPEUTICS EC US03152W1099 71,082 1,147 1.64 911 18.31 0.0152
2024-01-24 2023-11-30 NP AMICUS THERAPEUTICS EC US03152W1099 69,935 111 0.16 771 -13.97 0.0148
2023-10-27 2023-08-31 NP AMICUS THERAPEUTICS EC US03152W1099 69,824 1,110 1.62 895 15.78 0.0175
2023-07-26 2023-05-31 NP AMICUS THERAPEUTICS EC US03152W1099 68,714 222 0.32 774 -14.40 0.0167
2023-04-27 2023-02-28 NP AMICUS THERAPEUTICS EC US03152W1099 68,492 1,665 2.49 903 11.76 0.0221
2023-01-26 2022-11-30 NP AMICUS THERAPEUTICS EC US03152W1099 66,827 1,739 2.67 809 10.68 0.0202
2022-10-26 2022-08-31 NP AMICUS THERAPEUTICS EC US03152W1099 65,088 2,479 3.96 731 53.04 0.0183
2022-07-29 2022-05-31 NP AMICUS THERAPEUTICS EC US03152W1099 62,609 1,924 3.17 477 -3.25 0.0122
2022-04-28 2022-02-28 NP AMICUS THERAPEUTICS EC US03152W1099 60,685 962 1.61 494 -22.85 0.0114
2022-01-25 2021-11-30 NP AMICUS THERAPEUTICS EC US03152W1099 59,723 1,591 2.74 640 -3.47 0.0134
2021-10-26 2021-08-31 NP AMICUS THERAPEUTICS EC US03152W1099 58,132 1,221 2.15 662 25.86 0.0145
2021-07-22 2021-05-31 NP AMICUS THERAPEUTICS EC US03152W1099 56,911 210 0.37 527 -24.43 0.0131
2021-04-23 2021-02-28 NP AMICUS THERAPEUTICS EC US03152W1099 56,701 3,375 6.33 696 -42.95 0.0181
2021-01-20 2020-11-30 NP AMICUS THERAPEUTICS EC US03152W1099 53,326 -75 -0.14 1,221 56.61 0.0365
2020-10-16 2020-08-31 NP AMICUS THERAPEUTICS EC US03152W1099 53,401 975 1.86 780 19.11 0.0241
2020-07-20 2020-05-31 NP AMICUS THERAPEUTICS EC US03152W1099 52,426 -4,964 -8.65 654 19.56 0.0255
2020-04-24 2020-02-29 NP AMICUS THERAPEUTICS EC US03152W1099 57,390 27,922 94.75 548 77.60 0.0244
2020-01-16 2019-11-30 NP AMICUS THERAPEUTICS EC US03152W1099 29,468 29,468 309 0.0140
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.